Challenges in Colorectal Cancer
2. Edition June 2006
296 Pages, Hardcover
Wiley & Sons Ltd
The latest guidance on challenging and controversial aspects of
colorectal cancer
Colorectal cancer is one of the most common forms of cancer in
the US and Europe. Thousands of people are diagnosed with the
disease every year and nearly half of these die as a result. As
colorectal cancer is curable when detected early, a significant
proportion of these deaths could be prevented by earlier
diagnosis.
Much has changed since the publication of the first edition of
this book in 2001: introduction of screening programs, improved
diagnosis and surgery for rectal cancer, and advances in adjuvant
and palliative medical therapy to name but a few.
Challenges in Colorectal Cancer provides the most
up-to-date information on the new and emerging treatments. The
second edition looks at the total patient management of this
condition and is aimed at the entire medical team caring for those
with colorectal cancer. It also contains the latest guidelines on
epidemiology and prevention of colorectal cancer, and the
application of molecular genetics.
The expanded international editor team present advice on
surgical management, including new laparoscopic and endoscopic
techniques and the role of the pathologist. They also review hot
topics in colorectal cancer treatment, including the role of
radiotherapy, options for chemotherapy and new developments in
vaccines and immunotherapy.
2 Screening for colorectal cancer - who, when, and
how?.
3 What can the pathologist tell the multidisciplinary team about
rectal cancer resection?.
4 MRI-directed rectal cancer surgery.
5 Minimally invasive surgery - where are we? Laparoscopic
surgery for cancer of the colon and rectum.
6 Minimally invasive surgery - where are we? Is there a
role for TEM?.
7 What is the best strategy for the management of hereditary
colorectal cancer?.
8 Adjuvant radiotherapy and chemoradiotherapy in the treatment
of rectal cancer.
9 Current challenges in the adjuvant therapy of colon
cancer.
10 The role of the colorectal nurse specialist in the management
of colorectal cancer.
11 The role of the multidisciplinary team in the management of
colorectal cancer.
12 Follow-up after colorectal cancer resection: Is it
worthwhile?.
13 Chemotherapy of advanced colorectal cancer.
14 Surgery for metastatic disease in colorectal cancer.
15 Palliative care of the colorectal cancer patient.
16 Future directions in the oncological treatment of colorectal
cancer.
Index
Colorectal Disease, 2007
"A good book looking at the total management of patients with this condition and aimed at the entire medical team caring fro those with colorectal cancer."
Digestive and Liver Disease, 2007
From a review of the first edition:
"More knowledge of molecular biology, better definition of risk groups, better screening, further development of risk- oriented combination therapy, and more meticulous surgery may yield much higher cure rates for colon and rectal cancer. Scholefield's book is one of the best starting points for a journey through the world of established, new, and evolving treatments for these diseases."
New England Journal of Medicine, September 2000
"Robert W Beart, Jr., states in the foreword that this book provides an "up-to-date record of the rapidly evolving alternatives" in chapters which span the gamut from prevention through palliation. It is written for subspecialist physicians, nurses, and other members of the medical team. The emphasis throughout is providing this team with concrete, useful information. Although the authors are predominantly from the U.K., European and American issues are identified throughout." (Carol Scott-Conner, MD, PhD, MBA, @Doody's Review Service)
University Hospital in Nottingham. He is doing research into
possible screening tests for spotting colorectal cancer early and
cell changes in colorectal cancer. He chairs the National Cancer
Research Institute's colorectal cancer group, and is also a member
of Council of the Association of Surgeons.
Professor Herand Abcarian MD FACS, Turi Josefsen
Professor and Chairman of the Department of Surgery, University of
Illinois College of Medicine at Chicago, USA.
Professor Tim Maughan, Professor of Cancer Studies at the
University of Wales, College of Medicine, and Consultant Clinical
Oncologist at the Velindre Hospital Swansea. Also Chairman of the
All Wales Cancer Network.
Professor Axel Grothey, Mayo Clinic, USA (formerly
Professor of Medicine and Oncology at Martin Luther University,
Halle, Germany).
